Bristol Myers Squibb to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 8:10 a.m. ET in New York City. Executive Vice Presidents Chris Boerner, Ph.D., and Samit Hirawat, M.D., will address questions regarding the company's operations. A live webcast will be accessible at investor.bms.com, with an archived version available later that day.

Bristol Myers Squibb focuses on developing innovative medicines for serious diseases.

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Morgan Stanley 20^th Annual Global Healthcare Conference on Monday, September 12, 2022 in New York City. Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer and Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development will answer questions about the company at 8:10 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005032/en/

Bristol Myers Squibb



Media:

media@bms.com



Investor Relations:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When will Bristol Myers Squibb participate in the Morgan Stanley Global Healthcare Conference?

Bristol Myers Squibb will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022.

What time is the Bristol Myers Squibb session at the conference?

The Bristol Myers Squibb session is scheduled for 8:10 a.m. ET.

Who will represent Bristol Myers Squibb at the conference?

Chris Boerner, Ph.D., and Samit Hirawat, M.D., will represent Bristol Myers Squibb at the conference.

How can I listen to the Bristol Myers Squibb conference session?

You can listen to the Bristol Myers Squibb conference session live at http://investor.bms.com.

Will the Bristol Myers Squibb conference session be archived?

Yes, an archived edition of the Bristol Myers Squibb conference session will be available later that day.